We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Investors Sue Andrx Amid FDA Skirmish

Law360 (October 19, 2005, 12:00 AM EDT) -- Investors took legal action against drug maker Andrx Corp. Tuesday, accusing the pharmaceutical company of violating federal securities laws and misrepresenting the approval status of new drug applications with the U.S. Food and Drug Administration.

The class action suit was filed in the U.S. District Court for the Southern District of Florida, where investors vented over Andrx’s alleged inability to implement quality manufacturing practices at its facilities. The allegations cover the six-month period between March 09, 2005 and September 05, 2005.

Investors claim Florida-based Andrx and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.